Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs KRNY vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
PROV vs KRNY vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $109M | $553M | $896.00B |
| Revenue (TTM) | $60M | $344M | $280.33B |
| Net Income (TTM) | $7M | $32M | $57.05B |
| Gross Margin | 67.8% | 47.7% | 60.0% |
| Operating Margin | 16.2% | 11.6% | 25.9% |
| Forward P/E | 15.4x | 14.1x | 14.4x |
| Total Debt | $213M | $1.26B | $942.38B |
| Cash & Equiv. | $53M | $167M | $343.34B |
PROV vs KRNY vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Kearny Financial Co… (KRNY) | 100 | 107.5 | +7.5% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs KRNY vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.21, yield 3.3%
- Lower volatility, beta 0.21, current ratio 0.06x
- NIM 2.8% vs KRNY's 1.7%
KRNY carries the broadest edge in this set and is the clearest fit for growth exposure and defensive.
- Rev growth 5.1%, EPS growth 130.2%
- Beta 0.72, yield 5.0%, current ratio 1.20x
- 5.1% NII/revenue growth vs PROV's 2.5%
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs PROV's 25.8%
- Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs PROV's 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.1% NII/revenue growth vs PROV's 2.5% | |
| Value | Lower P/E (14.1x vs 15.4x) | |
| Quality / Margins | Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs JPM's 0.94, lower leverage | |
| Dividends | 5.0% yield, vs JPM's 1.9% | |
| Momentum (1Y) | +45.1% vs PROV's +14.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs PROV's 0.5% |
PROV vs KRNY vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PROV vs KRNY vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to KRNY's 9.4%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $60M | $344M | $280.3B |
| EBITDAEarnings before interest/tax | $12M | $43M | $81.4B |
| Net IncomeAfter-tax profit | $7M | $32M | $57.0B |
| Free Cash FlowCash after capex | $9M | $40M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +67.8% | +47.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +11.6% | +25.9% |
| Net MarginNet income ÷ Revenue | +11.0% | +9.4% | +20.4% |
| FCF MarginFCF ÷ Revenue | +15.3% | +11.6% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | +50.0% | +16.0% |
Valuation Metrics
Evenly matched — KRNY and JPM each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 24% valuation discount to KRNY's 20.9x P/E. On an enterprise value basis, JPM's 18.4x EV/EBITDA is more attractive than KRNY's 45.8x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $109M | $553M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $269M | $1.6B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 20.93x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 14.06x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 21.77x | 45.76x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 1.61x | 3.20x |
| Price / BookPrice ÷ Book value/share | 0.90x | 0.74x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 25.84x | 8.88x |
Profitability & Efficiency
JPM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $4 for KRNY. PROV carries lower financial leverage with a 1.66x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), KRNY scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +4.3% | +15.9% |
| ROA (TTM)Return on assets | +0.5% | +0.4% | +1.3% |
| ROICReturn on invested capital | +1.9% | +1.1% | +4.5% |
| ROCEReturn on capital employed | +2.4% | +1.5% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 1.66x | 1.68x | 2.60x |
| Net DebtTotal debt minus cash | $160M | $1.1B | $599.0B |
| Cash & Equiv.Liquid assets | $53M | $167M | $343.3B |
| Total DebtShort + long-term debt | $213M | $1.3B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 0.22x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $8,728 for KRNY. Over the past 12 months, KRNY leads with a +45.1% total return vs PROV's +14.5%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs KRNY's 10.6% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +22.6% | -0.5% |
| 1-Year ReturnPast 12 months | +14.5% | +45.1% | +21.8% |
| 3-Year ReturnCumulative with dividends | +50.9% | +35.2% | +138.2% |
| 5-Year ReturnCumulative with dividends | +18.2% | -12.7% | +118.2% |
| 10-Year ReturnCumulative with dividends | +25.8% | -7.2% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +10.6% | +33.6% |
Risk & Volatility
Evenly matched — PROV and KRNY each lead in 1 of 2 comparable metrics.
Risk & Volatility
PROV is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KRNY currently trades 99.9% from its 52-week high vs JPM's 95.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.72x | 0.94x |
| 52-Week HighHighest price in past year | $17.42 | $8.79 | $337.25 |
| 52-Week LowLowest price in past year | $14.95 | $5.76 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +99.9% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 66.7 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 293K | 7.0M |
Analyst Outlook
Evenly matched — KRNY and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", KRNY as "Hold", JPM as "Buy". Consensus price targets imply 8.1% upside for KRNY (target: $10) vs -6.5% for PROV (target: $16). For income investors, KRNY offers the higher dividend yield at 5.01% vs JPM's 1.86%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $16.00 | $9.50 | $339.75 |
| # AnalystsCovering analysts | 10 | 5 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +5.0% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 |
| Dividend / ShareAnnual DPS | $0.56 | $0.44 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +0.1% | +3.9% |
JPM leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
PROV vs KRNY vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or KRNY or JPM a better buy right now?
For growth investors, Kearny Financial Corp.
(KRNY) is the stronger pick with 5. 1% revenue growth year-over-year, versus 2. 5% for Provident Financial Holdings, Inc. (PROV). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or KRNY or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Kearny Financial Corp. at 20. 9x. On forward P/E, Kearny Financial Corp. is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PROV or KRNY or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -12. 7% for Kearny Financial Corp. (KRNY). Over 10 years, the gap is even starker: JPM returned +465. 8% versus KRNY's -7. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or KRNY or JPM?
By beta (market sensitivity over 5 years), Provident Financial Holdings, Inc.
(PROV) is the lower-risk stock at 0. 21β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 357% more volatile than PROV relative to the S&P 500. On balance sheet safety, Provident Financial Holdings, Inc. (PROV) carries a lower debt/equity ratio of 166% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or KRNY or JPM?
By revenue growth (latest reported year), Kearny Financial Corp.
(KRNY) is pulling ahead at 5. 1% versus 2. 5% for Provident Financial Holdings, Inc. (PROV). On earnings-per-share growth, the picture is similar: Kearny Financial Corp. grew EPS 130. 2% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or KRNY or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 7. 6% for Kearny Financial Corp. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 9. 0% for KRNY. At the gross margin level — before operating expenses — PROV leads at 65. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or KRNY or JPM more undervalued right now?
On forward earnings alone, Kearny Financial Corp.
(KRNY) trades at 14. 1x forward P/E versus 15. 4x for Provident Financial Holdings, Inc. — 1. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KRNY: 8. 1% to $9. 50.
08Which pays a better dividend — PROV or KRNY or JPM?
All stocks in this comparison pay dividends.
Kearny Financial Corp. (KRNY) offers the highest yield at 5. 0%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is PROV or KRNY or JPM better for a retirement portfolio?
For long-horizon retirement investors, Provident Financial Holdings, Inc.
(PROV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 3% yield). Both have compounded well over 10 years (PROV: +25. 8%, KRNY: -7. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and KRNY and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; KRNY is a small-cap income-oriented stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.